A systematic review of apixaban in prevention and treatment of cancer-associated venous thromboembolism.

Caputo, Ryan; Pyle, Jacqueline; Kuriakose, Philip; Lekura, Jona

Caputo, Ryan; Pyle, Jacqueline; Kuriakose, Philip; Lekura, Jona.

J Am Pharm Assoc (2003) ; 61(5): e26-e38, 2021.

Article in En | MEDLINE | ID: mdl-34229946

Subject(s)

Neoplasms; Venous Thromboembolism; Administration, Oral; Anticoagulants/adverse effects; Humans; Neoplasms/complications; Neoplasms/drug therapy; Pyrazoles/adverse effects; Pyridones/adverse effects; Venous Thromboembolism/drug therapy; Venous Thromboembolism/etiology; Venous Thromboembolism/prevention & control

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Venous Thromboembolism / Neoplasms Type of study: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: J Am Pharm Assoc (2003) Journal subject: FARMACIA Year: 2021 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google